Diabetes Is an Independent Predictor for Severe OsteoarthritisGeorg Schett, Stefan Kiechl, Arnd Kleyer et al.|Diabetes Care|2012Cited by 334
A Phase <scp>II</scp> Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With SynovitisRoy Fleischmann, Marc C. Levesque, Philip G. Conaghan et al.|Arthritis & Rheumatology|2019Cited by 209
2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseasesAnnette de Thurah, Christian Dejaco, Philipp Bösch et al.|Annals of the Rheumatic Diseases|2022Cited by 131
Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritisC. Meurot, Françis Berenbaum|Scientific Reports|2022Cited by 129